Hot Features
Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-05-29 | Mr. Robert Melvin-Douglas CrossIndependent Non-Executive Chairman | -25,00k | 99,02k | Verkauf | 3,96 | 51,40k | -32,72% |
| 2026-04-02 | Dr. James Andrew RobinsonPresident, COO & Director | 10,00k | 33,99k | Kauf | 3,40 | 3,28M | 0,31% |
| 2026-03-31 | Mr. Salah I. GamoudiCFO | 105,80k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 2,31 | 958,62k | 12,41% |
| 2026-03-31 | Mr. Michael BarmanChief Development Officer | 72,55k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 2,31 | 837,68k | 9,48% |
| 2026-03-31 | Dr. James Andrew RobinsonPresident, COO & Director | 212,80k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 2,31 | 1,67M | 14,60% |
| 2026-03-31 | Mr. David ParkCEO & Director | 327,06k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 2,31 | 2,92M | 12,60% |
| 2026-04-01 | Dr. James Andrew RobinsonPresident, COO & Director | 10,00k | 34,85k | Kauf | 3,48 | 3,27M | 0,31% |
| 2026-03-31 | Mr. David ParkCEO & Director | -505,52k | 0,00 | Other Disposition | - | 1,62M | -23,77% |
| 2026-03-30 | Mr. David ParkCEO & Director | -161,15k | 0,00 | Derivative Exercise and Sale | - | 1,62M | - |
| 2026-03-31 | Mr. David ParkCEO & Director | -2,00M | 0,00 | Other Derivative Disposition | - | 0,00 | -100,00% |
| 2026-03-26 | Mr. Salah I. GamoudiCFO | 39,67k | 0,00 | Derivative Exercise and Retained Stock | - | 106,70k | 59,18% |
| 2026-03-26 | Ms. Karen G. NarwoldIndependent Director | 55,76k | 0,00 | Derivative Exercise and Retained Stock | - | 55,76k | - |
| 2026-03-26 | Mr. Michael BarmanChief Development Officer | 15,25k | 56,58k | Derivative Exercise and Retained Stock | 3,71 | 159,60k | 10,57% |
| 2026-03-26 | Dr. James Andrew RobinsonPresident, COO & Director | 40,71k | 0,00 | Derivative Exercise and Retained Stock | - | 3,26M | 1,27% |
| 2026-02-03 | Mr. David ParkCEO & Director | 111,86k | 499,82k | Kauf | 4,47 | 1,46M | 8,30% |
| 2026-01-27 | Mr. Robert Melvin-Douglas CrossIndependent Non-Executive Chairman | -100,00k | 540,62k | Derivative Exercise and Sale | 5,41 | 76,40k | - |
| 2026-01-15 | Mr. Jeffrey BarberIndependent Director | 200,00k | 0,00 | Derivative Exercise and Retained Stock | - | 630,00k | 46,51% |
| 2026-01-12 | Dr. James Andrew RobinsonPresident, COO & Director | 75,93k | 0,00 | Derivative Exercise and Retained Stock | - | 3,22M | 2,42% |
| 2026-01-12 | Dr. James Andrew RobinsonPresident, COO & Director | -124,08k | 636,48k | Derivative Exercise and Sale | 5,13 | 3,22M | - |
| 2025-12-18 | Mr. David ParkCEO & Director | 50,88k | 1,88B | Derivative Exercise and Retained Stock | 36,97k | 1,35M | 3,92% |
| 2025-12-18 | Dr. James Andrew RobinsonPresident, COO & Director | 21,75k | 0,00 | Derivative Exercise and Retained Stock | - | 3,14M | 0,70% |
| 2025-12-18 | Dr. James Andrew RobinsonPresident, COO & Director | -25,20k | 126,48k | Derivative Exercise and Sale | 5,02 | 3,14M | - |
| 2025-12-18 | Mr. Salah I. GamoudiCFO | 19,40k | 0,00 | Derivative Exercise and Retained Stock | - | 67,03k | 40,74% |
| 2025-12-18 | Mr. Salah I. GamoudiCFO | -6,27k | 31,49k | Derivative Exercise and Sale | 5,02 | 67,03k | - |
| 2025-12-18 | Mr. Michael BarmanChief Development Officer | 8,15k | 0,00 | Derivative Exercise and Retained Stock | - | 144,34k | 5,98% |
| 2025-12-18 | Mr. Michael BarmanChief Development Officer | -9,45k | 47,46k | Derivative Exercise and Sale | 5,02 | 144,34k | - |
| 2025-12-09 | Mr. Robert Melvin-Douglas CrossIndependent Non-Executive Chairman | -200,00k | 954,94k | Derivative Exercise and Sale | 4,77 - 4,78 | 76,40k | - |
| 2025-11-12 | Mr. David ParkCEO & Director | 296,50k | 997,84k | Kauf | 3,28 - 3,37 | 1,30M | 29,64% |
| 2025-10-09 | Mr. Robert Melvin-Douglas CrossIndependent Non-Executive Chairman | -75,00k | 342,03k | Verkauf | 4,45 - 4,61 | 76,40k | -49,54% |
| 2025-09-29 | Mr. Robert Melvin-Douglas CrossIndependent Non-Executive Chairman | -100,00k | 348,58k | Verkauf | 3,49 | 151,40k | -39,78% |
| 2025-09-29 | Dr. James Andrew RobinsonPresident, COO & Director | -220,14k | 744,48k | Derivative Exercise and Sale | 3,38 | 3,12M | - |
| 2025-09-29 | Dr. James Andrew RobinsonPresident, COO & Director | 229,86k | 0,00 | Derivative Exercise and Retained Stock | - | 3,12M | 7,96% |
| 2025-09-05 | Mr. Robert Melvin-Douglas CrossIndependent Non-Executive Chairman | -75,00k | 225,01k | Verkauf | 3,00 | 251,40k | -22,98% |
| 2025-08-09 | Mr. Michael BarmanChief Development Officer | 44,19k | 0,00 | Derivative Exercise and Retained Stock | - | 136,19k | 48,04% |
| 2025-08-12 | Dr. James Andrew RobinsonPresident, COO & Director | -67,58k | 190,60k | Disposition Under Employee Benefit Plan | 2,82 | 2,89M | -2,29% |
| 2025-08-12 | Mr. Salah I. GamoudiCFO | -16,82k | 47,44k | Disposition Under Employee Benefit Plan | 2,82 | 47,63k | -26,10% |
| 2025-08-09 | Dr. James Andrew RobinsonPresident, COO & Director | 117,49k | 0,00 | Derivative Exercise and Retained Stock | - | 2,89M | 4,24% |
| 2025-08-09 | Mr. Salah I. GamoudiCFO | 64,45k | 0,00 | Derivative Exercise and Retained Stock | - | 47,63k | -383,17% |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
